| Pharmaceutical active ingredients: |
| Ganciclovir |
| Available forms, composition and doses of Biolf 62: |
| N / A |
| Biolf 62 medical category: |
| Human:AntiviralsNucleosides and nucleotides |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AB06 - GanciclovirS01AD09 - Ganciclovir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Biofusal | Fusafungine | Unidentified Pharmaceutical Company |
| Biogas | Carbon Black | Unidentified Pharmaceutical Company |
| Biogenic SE 374 | Limonene | Unidentified Pharmaceutical Company |
| Bioglumin | Chlorpropamide | Unidentified Pharmaceutical Company |
| Bioguard | Thiabendazole | Unidentified Pharmaceutical Company |
| Bio-Luton | Progesterone | Unidentified Pharmaceutical Company |
| Biomitsin | Lymecycline | Unidentified Pharmaceutical Company |
| Biomycin | Lymecycline | Unidentified Pharmaceutical Company |
| Biomydrin | Phenylephrine | Unidentified Pharmaceutical Company |
| Bion NE 9 | Nonoxynol 9 | Unidentified Pharmaceutical Company |